Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (42)

2022

  1. Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity

    Epigenetics, Vol. 17, Núm. 1, pp. 81-92

  2. Effects of gut microbiota–derived extracellular vesicles on obesity and diabetes and their potential modulation through diet

    Journal of Physiology and Biochemistry, Vol. 78, Núm. 2, pp. 485-499

2021

  1. A predictive regression model of the obesity-related inflammatory status based on gut microbiota composition

    International Journal of Obesity, Vol. 45, Núm. 10, pp. 2261-2268

  2. Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3279-3301

  3. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057

  4. Gut microbiota bacterial species associated with mediterranean diet-related food groups in a northern spanish population

    Nutrients, Vol. 13, Núm. 2, pp. 1-17

  5. Gut microbiota differences according to ultra-processed food consumption in a spanish population

    Nutrients, Vol. 13, Núm. 8

  6. Potential Mechanisms Linking Food-Derived MicroRNAs, Gut Microbiota and Intestinal Barrier Functions in the Context of Nutrition and Human Health

    Frontiers in Nutrition, Vol. 8

  7. The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits

    Scientific reports, Vol. 11, Núm. 1, pp. 21859

  8. Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study

    Diagnostics, Vol. 11, Núm. 6

2020

  1. Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease

    Nutrients, Vol. 12, Núm. 5

  2. Circulating adiposity-related microRNAs as predictors of the response to a low-fat diet in subjects with obesity

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 2956-2967

  3. Comprehensive analysis reveals novel interactions between circulating micrornas and gut microbiota composition in human obesity

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-17

  4. Crosstalk between circulating microRNAs and chronotypical features in subjects with metabolic syndrome

    Chronobiology International, pp. 1-11

  5. Interplay of an obesity-based genetic risk score with dietary and endocrine factors on insulin resistance

    Nutrients, Vol. 12, Núm. 1

  6. Modeling of an integrative prototype based on genetic, phenotypic, and environmental information for personalized prescription of energy-restricted diets in overweight/obese subjects

    American Journal of Clinical Nutrition, Vol. 111, Núm. 2, pp. 459-470

  7. PPARGC1A gene promoter methylation as a biomarker of insulin secretion and sensitivity in response to glucose challenges

    Nutrients, Vol. 12, Núm. 9, pp. 1-15

  8. Sex-specific associations between gut prevotellaceae and host genetics on adiposity

    Microorganisms, Vol. 8, Núm. 6, pp. 1-19

2019

  1. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: A comparison with healthy controls

    Nutrients, Vol. 11, Núm. 2

  2. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes

    Nutrition and Cancer, Vol. 71, Núm. 5, pp. 840-851